Powell Investment Advisors, LLC Abb Vie Inc. Transaction History

Powell Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $232,221 - $255,647	-2,270 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$80.49 - $108.67 $5,553 - $7,498	-69 Reduced 2.95%	2,270 $243,000
Q3 2020 Oct 07, 2020	BUY	$85.91 - $100.83 $171 - $201	2 Added 0.09%	2,339 $205,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $171,465 - $229,446	2,337 New	2,337 $229,000
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $150,414 - $228,046	-2,332 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $168,207 - $210,463	2,332 New	2,332 $207,000

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Powell Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Powell Investment Advisors, LLC with notifications on news.